Literature DB >> 23489335

Tissue-specific effector functions of innate lymphoid cells.

Niklas K Björkström1, Eliisa Kekäläinen, Jenny Mjösberg.   

Abstract

Innate lymphoid cells (ILCs) is the collective term for a group of related innate lymphocytes, including natural killer (NK) cells and the more recently discovered non-NK ILCs, which all lack rearranged antigen receptors such as those expressed by T and B cells. Similar to NK cells, the newly discovered ILCs depend on the transcription factor Id2 and the common γ-chain of the interleukin-2 receptor for development. However, in contrast to NK cells, non-NK ILCs also require interleukin-7. In addition to the cytotoxic functions of NK cells, assuring protection against tumour development and viruses, new data indicate that ILCs contribute to a wide range of homeostatic and pathophysiological conditions in various organs via specialized cytokine production capabilities. Here we summarize current knowledge on ILCs with a particular emphasis on their tissue-specific effector functions, in the gut, liver, lungs and uterus. When possible, we try to highlight the role that these cells play in humans.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  effector functions; innate lymphoid cells; natural killer cells; tissue immunology

Mesh:

Substances:

Year:  2013        PMID: 23489335      PMCID: PMC3719059          DOI: 10.1111/imm.12098

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  145 in total

1.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Authors:  H Daniel Lacorazza; Yasushi Miyazaki; Antonio Di Cristofano; Anthony Deblasio; Cyrus Hedvat; Jin Zhang; Carlos Cordon-Cardo; Shifeng Mao; Pier Paolo Pandolfi; Stephen D Nimer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

2.  Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.

Authors:  Hiroshi Chinen; Katsuyoshi Matsuoka; Toshiro Sato; Nobuhiko Kamada; Susumu Okamoto; Tadakazu Hisamatsu; Taku Kobayashi; Hirotoshi Hasegawa; Akira Sugita; Fukunori Kinjo; Jiro Fujita; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

3.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.

Authors:  Espen Melum; Andre Franke; Christoph Schramm; Tobias J Weismüller; Daniel Nils Gotthardt; Felix A Offner; Brian D Juran; Jon K Laerdahl; Verena Labi; Einar Björnsson; Rinse K Weersma; Liesbet Henckaerts; Andreas Teufel; Christian Rust; Eva Ellinghaus; Tobias Balschun; Kirsten Muri Boberg; David Ellinghaus; Annika Bergquist; Peter Sauer; Euijung Ryu; Johannes Roksund Hov; Jochen Wedemeyer; Björn Lindkvist; Michael Wittig; Robert J Porte; Kristian Holm; Christian Gieger; H-Erich Wichmann; Pieter Stokkers; Cyriel Y Ponsioen; Heiko Runz; Adolf Stiehl; Cisca Wijmenga; Martina Sterneck; Severine Vermeire; Ulrich Beuers; Andreas Villunger; Erik Schrumpf; Konstantinos N Lazaridis; Michael P Manns; Stefan Schreiber; Tom H Karlsen
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

5.  Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells.

Authors:  Yong-Oon Ahn; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

6.  Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection.

Authors:  Laura Denney; Celia Aitken; Chris Ka-Fai Li; Eleri Wilson-Davies; Wai Ling Kok; Colin Clelland; Kevin Rooney; Duncan Young; Tao Dong; Andrew J McMichael; William F Carman; Ling-Pei Ho
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

7.  Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

Authors:  Hye Young Kim; Ya-Jen Chang; Srividya Subramanian; Hyun-Hee Lee; Lee A Albacker; Ponpan Matangkasombut; Paul B Savage; Andrew N J McKenzie; Dirk E Smith; James B Rottman; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-11-25       Impact factor: 10.793

Review 8.  Organ-specific features of natural killer cells.

Authors:  Fu-Dong Shi; Hans-Gustaf Ljunggren; Antonio La Cava; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

9.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

10.  IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease.

Authors:  Christian Taube; Christine Tertilt; Gabor Gyülveszi; Nina Dehzad; Katharina Kreymborg; Kristin Schneeweiss; Erich Michel; Sebastian Reuter; Jean-Christophe Renauld; Danielle Arnold-Schild; Hansjörg Schild; Roland Buhl; Burkhard Becher
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

View more
  16 in total

Review 1.  Group 2 innate lymphoid cells in health and disease.

Authors:  Brian S Kim; David Artis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-08       Impact factor: 10.005

2.  Increased expression of type 2 innate lymphoid cells in pediatric patients with allergic rhinitis.

Authors:  Rong Sun; Yang Yang; Qianzhu Huo; Zheng Gu; Ping Wei; Xinye Tang
Journal:  Exp Ther Med       Date:  2019-11-22       Impact factor: 2.447

Review 3.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

Review 4.  Emerging insights into natural killer cells in human peripheral tissues.

Authors:  Niklas K Björkström; Hans-Gustaf Ljunggren; Jakob Michaëlsson
Journal:  Nat Rev Immunol       Date:  2016-04-28       Impact factor: 53.106

Review 5.  Innate lymphoid cells and allergic inflammation.

Authors:  Brian S Kim; Elia D Tait Wojno; David Artis
Journal:  Curr Opin Immunol       Date:  2013-08-31       Impact factor: 7.486

Review 6.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

Review 7.  Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.

Authors:  James Lm Ferrara; Christopher M Smith; Julia Sheets; Pavan Reddy; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-06-05       Impact factor: 14.808

Review 8.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 9.  Phenotype and functions of conventional and non-conventional NK cells.

Authors:  Timothy K Erick; Laurent Brossay
Journal:  Curr Opin Immunol       Date:  2015-12-17       Impact factor: 7.486

10.  NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging.

Authors:  Ulrike Hoffmann; Christine Neudörfl; Kerstin Daemen; Jana Keil; Maja Stevanovic-Meyer; Frank Lehner; Hermann Haller; Cornelia Blume; Christine S Falk
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.